Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

v3.23.3
Stockholders' Deficit (Tables)
9 Months Ended
Sep. 30, 2023
Stockholders' Deficit [Abstract]  
Schedule of Warrants Outstanding The following table summarizes our warrants outstanding as of the dates presented:
    Exercise
Price
    Expiration
Date
  Balance
as of
December 31,
2022
    Issued     Exercised     Expired    

Balance
as of

September 30,

2023

 
2019 Public Warrants (1)   $ 230.00     6/19/2024     5,813,804      
    —
     
       —
     
      5,813,804  
2022 Unit Offering                                                    
Common Warrants (2)   $ 0.37     6/29/2027     43,478,261      
     
     
      43,478,261  
Underwriter Warrants (2)   $ 0.37     6/29/2027     2,173,913      
     
     
      2,173,913  
                  51,465,978      
     
     
      51,465,978  
(1) The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.
(2) In connection with the PIPE Investment, the exercise price of the Common Warrants and Underwriter Warrants was reduced from $0.88 per shares to $0.37 per share and are exercisable for a combined amount of 2,282,609 shares of Common Stock at $0.37 per share or a ratio of 20 warrants for one share of Common Stock.